Jonathan McNeill, Chief Business Officer at Dyne Therapeutics, Inc. (DYN), sold 3,646 shares at $31.34 ($114K) on 2024-06-11, disclosed to the SEC on 2024-06-11.
Open-market sale of $114k DYN by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.34 | 1,823 | $57K | 50.0% |
| 2 | $31.34 | 1,823 | $57K | 50.0% |
| Total | $31.34 avg | 3,646 | $114K | 100% |
| Filing → |
| DYN | SELL | 2024-08-20 | $122K | — | Filing → |
| DYN | SELL | 2024-05-17 | $143K | — | Filing → |
| DYN | SELL | 2024-03-13 | $5.2M | — | Filing → |